InsidersTradesSigma
Explore the complete record of transactions filed by Amin Dipti, Director. Officer active across 1 companies, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 1 disclosures have been logged. Total volume traded: €52k. The latest transaction was filed on 28 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Amin Dipti is a Director of Lineage Cell Therapeutics, Inc. In this role, she participates in the governance of the company and in strategic decision-making. Her expertise in the biotechnology field helps to guide the company's policies.